Abstract
The structure of the mammalian lung controls the flow of air through the airways and into the distal alveolar region where gas exchange occurs. Specialized cells in the lung mesenchyme produce the extracellular matrix (ECM) and growth factors required for lung structure. Historically, characterizing the mesenchymal cell subtypes was challenging due to their ambiguous morphology, overlapping expression of protein markers, and limited cell-surface molecules needed for isolation. The recent development of single-cell RNA sequencing (scRNA-seq) complemented with genetic mouse models demonstrated that the lung mesenchyme comprises transcriptionally and functionally heterogeneous cell-types. Bioengineering approaches that model tissue structure clarify the function and regulation of mesenchymal cell types. These experimental approaches demonstrate the unique abilities of fibroblasts in mechanosignaling, mechanical force generation, ECM production, and tissue regeneration. This chapter will review the cell biology of the lung mesenchyme and experimental approaches to study their function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bellusci, S., Grindley, J., Emoto, H., Itoh, N. & Hogan, B.L. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124, 4867–4878 (1997).
Daley, W.P. & Yamada, K.M. ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr Opin Genet Dev 23, 408–414 (2013).
De Langhe, S.P., et al. Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung. Dev Biol 277, 316–331 (2005).
Gebb, S.A., Fox, K., Vaughn, J., McKean, D. & Jones, P.L. Fetal oxygen tension promotes tenascin-C-dependent lung branching morphogenesis. Dev Dyn 234, 1–10 (2005).
McCulley, D., Wienhold, M. & Sun, X. The pulmonary mesenchyme directs lung development. Curr Opin Genet Dev 32, 98–105 (2015).
Roth-Kleiner, M., Hirsch, E. & Schittny, J.C. Fetal lungs of tenascin-C-deficient mice grow well, but branch poorly in organ culture. Am J Respir Cell Mol Biol 30, 360–366 (2004).
Volckaert, T., et al. Localized Fgf10 expression is not required for lung branching morphogenesis but prevents differentiation of epithelial progenitors. Development 140, 3731–3742 (2013).
Whitsett, J.A., Kalin, T.V., Xu, Y. & Kalinichenko, V.V. Building and Regenerating the Lung Cell by Cell. Physiol Rev 99, 513–554 (2019).
Zepp, J.A. & Morrisey, E.E. Cellular crosstalk in the development and regeneration of the respiratory system. Nat Rev Mol Cell Biol 20, 551–566 (2019).
Nho, R.S., Ballinger, M.N., Rojas, M.M., Ghadiali, S.N. & Horowitz, J.C. Biomechanical Force and Cellular Stiffness in Lung Fibrosis. Am J Pathol 192, 750–761 (2022).
Wolters, P.J., et al. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med 6, 154–160 (2018).
Noble, P.W., Barkauskas, C.E. & Jiang, D. Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 122, 2756–2762 (2012).
Somogyi, V., et al. The therapy of idiopathic pulmonary fibrosis: what is next? Eur Respir Rev 28(2019).
Davidson, M.D., Burdick, J.A. & Wells, R.G. Engineered Biomaterial Platforms to Study Fibrosis. Adv Healthc Mater 9, e1901682 (2020).
Zepp, J.A., et al. Distinct Mesenchymal Lineages and Niches Promote Epithelial Self-Renewal and Myofibrogenesis in the Lung. Cell 170, 1134–1148 e1110 (2017).
Lee, J.H., et al. Anatomically and Functionally Distinct Lung Mesenchymal Populations Marked by Lgr5 and Lgr6. Cell 170, 1149–1163 e1112 (2017).
Zepp, J.A., et al. Genomic, epigenomic, and biophysical cues controlling the emergence of the lung alveolus. Science 371(2021).
Liu, X., et al. Categorization of lung mesenchymal cells in development and fibrosis. iScience 24, 102551 (2021).
Tsukui, T., et al. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis. Nat Commun 11, 1920 (2020).
Adams, T.S., et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv 6, eaba1983 (2020).
Habermann, A.C., et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis. Sci Adv 6, eaba1972 (2020).
Basil, M.C., et al. The Cellular and Physiological Basis for Lung Repair and Regeneration: Past, Present, and Future. Cell Stem Cell 26, 482–502 (2020).
Tata, P.R. & Rajagopal, J. Plasticity in the lung: making and breaking cell identity. Development 144, 755–766 (2017).
Wang, C., et al. Expansion of hedgehog disrupts mesenchymal identity and induces emphysema phenotype. J Clin Invest 128, 4343–4358 (2018).
O’Hare, K.H. & Sheridan, M.N. Electron microscopic observations on the morphogenesis of the albino rat lung, with special reference to pulmonary epithelial cells. Am J Anat 127, 181–205 (1970).
Brody, J.S. & Kaplan, N.B. Proliferation of alveolar interstitial cells during postnatal lung growth. Evidence for two distinct populations of pulmonary fibroblasts. Am Rev Respir Dis 127, 763–770 (1983).
Maksvytis, H.J., et al. In vitro characteristics of the lipid-filled interstitial cell associated with postnatal lung growth: evidence for fibroblast heterogeneity. J Cell Physiol 118, 113–123 (1984).
Barkauskas, C.E., et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 123, 3025–3036 (2013).
Chung, M.I., Bujnis, M., Barkauskas, C.E., Kobayashi, Y. & Hogan, B.L.M. Niche-mediated BMP/SMAD signaling regulates lung alveolar stem cell proliferation and differentiation. Development 145(2018).
Nabhan, A.N., Brownfield, D.G., Harbury, P.B., Krasnow, M.A. & Desai, T.J. Single-cell Wnt signaling niches maintain stemness of alveolar type 2 cells. Science 359, 1118–1123 (2018).
Sun, X., et al. A census of the lung: CellCards from LungMAP. Dev Cell 57, 112–145 e112 (2022).
Sims, D.E. The pericyte--a review. Tissue Cell 18, 153–174 (1986).
Weibel, E.R. On pericytes, particularly their existence on lung capillaries. Microvasc Res 8, 218–235 (1974).
Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21, 193–215 (2011).
Perros, F., et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178, 81–88 (2008).
Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A. & Betsholtz, C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047–3055 (1999).
Hung, C., et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 188, 820–830 (2013).
Chandran, R.R., et al. Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis. Nat Commun 12, 7179 (2021).
Rock, J.R., et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 108, E1475–1483 (2011).
Volckaert, T., et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest 121, 4409–4419 (2011).
Moiseenko, A., et al. Identification of a Repair-Supportive Mesenchymal Cell Population during Airway Epithelial Regeneration. Cell Rep 33, 108549 (2020).
Gouveia, L., et al. Lung developmental arrest caused by PDGF-A deletion: consequences for the adult mouse lung. Am J Physiol Lung Cell Mol Physiol 318, L831–L843 (2020).
Kugler, M.C., et al. Sonic Hedgehog Signaling Regulates Myofibroblast Function during Alveolar Septum Formation in Murine Postnatal Lung. Am J Respir Cell Mol Biol 57, 280–293 (2017).
Li, C., et al. Secondary crest myofibroblast PDGFRalpha controls the elastogenesis pathway via a secondary tier of signaling networks during alveologenesis. Development 146(2019).
Li, R., Li, X., Hagood, J., Zhu, M.S. & Sun, X. Myofibroblast contraction is essential for generating and regenerating the gas-exchange surface. J Clin Invest 130, 2859–2871 (2020).
Hagan, A.S., et al. Generation and validation of novel conditional flox and inducible Cre alleles targeting fibroblast growth factor 18 (Fgf18). Dev Dyn 248, 882–893 (2019).
Jain, R., et al. Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung. Nat Commun 6, 6727 (2015).
Nikolic, M.Z., et al. Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids. Elife 6(2017).
Gotoh, S., et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Reports 3, 394–403 (2014).
Liberti, D.C. & Morrisey, E.E. Organoid models: assessing lung cell fate decisions and disease responses. Trends Mol Med 27, 1159–1174 (2021).
Cassandras, M., et al. Gli1(+) mesenchymal stromal cells form a pathological niche to promote airway progenitor metaplasia in the fibrotic lung. Nat Cell Biol 22, 1295–1306 (2020).
Kathiriya, J.J., et al. Human alveolar type 2 epithelium transdifferentiates into metaplastic KRT5(+) basal cells. Nat Cell Biol 24, 10–23 (2022).
Chen, Y.W., et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat Cell Biol 19, 542–549 (2017).
Strikoudis, A., et al. Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. Cell Rep 27, 3709–3723 e3705 (2019).
Tan, Q., Choi, K.M., Sicard, D. & Tschumperlin, D.J. Human airway organoid engineering as a step toward lung regeneration and disease modeling. Biomaterials 113, 118–132 (2017).
Tan, Q., et al. Nascent Lung Organoids Reveal Epithelium- and Bone Morphogenetic Protein-mediated Suppression of Fibroblast Activation. Am J Respir Cell Mol Biol 61, 607–619 (2019).
Joshi, R., Batie, M.R., Fan, Q. & Varisco, B.M. Mouse lung organoid responses to reduced, increased, and cyclic stretch. Am J Physiol Lung Cell Mol Physiol 322, L162–L173 (2022).
Dye, B.R., et al. Human lung organoids develop into adult airway-like structures directed by physico-chemical biomaterial properties. Biomaterials 234, 119757 (2020).
Hofer, M. & Lutolf, M.P. Engineering organoids. Nat Rev Mater 6, 402–420 (2021).
Huh, D., et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010).
Huh, D., et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 4, 159ra147 (2012).
Stucki, A.O., et al. A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. Lab Chip 15, 1302–1310 (2015).
Zamprogno, P., et al. Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane. Commun Biol 4, 168 (2021).
Sellgren, K.L., Butala, E.J., Gilmour, B.P., Randell, S.H. & Grego, S. A biomimetic multicellular model of the airways using primary human cells. Lab Chip 14, 3349–3358 (2014).
Huang, D., et al. Reversed-engineered human alveolar lung-on-a-chip model. Proc Natl Acad Sci U S A 118(2021).
Nesmith, A.P., Agarwal, A., McCain, M.L. & Parker, K.K. Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. Lab Chip 14, 3925–3936 (2014).
Mejias, J.C., Nelson, M.R., Liseth, O. & Roy, K. A 96-well format microvascularized human lung-on-a-chip platform for microphysiological modeling of fibrotic diseases. Lab Chip 20, 3601–3611 (2020).
Lagowala, D.A., Kwon, S., Sidhaye, V.K. & Kim, D.H. Human microphysiological models of airway and alveolar epithelia. Am J Physiol Lung Cell Mol Physiol 321, L1072–L1088 (2021).
Burgstaller, G., et al. Distinct niches within the extracellular matrix dictate fibroblast function in (cell free) 3D lung tissue cultures. Am J Physiol Lung Cell Mol Physiol 314, L708–L723 (2018).
Gilpin, S.E. & Wagner, D.E. Acellular human lung scaffolds to model lung disease and tissue regeneration. Eur Respir Rev 27(2018).
Booth, A.J., et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med 186, 866–876 (2012).
Wagner, D.E., et al. Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35, 3281–3297 (2014).
Zhou, Y., et al. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med 6, 240ra276 (2014).
Sava, P., et al. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung. JCI Insight 2(2017).
Skibba, M., Drelich, A., Poellmann, M., Hong, S. & Brasier, A.R. Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis. Front Pharmacol 11, 607689 (2020).
Praphawatvet, T., Peters, J.I. & Williams, R.O., 3rd. Inhaled nanoparticles-An updated review. Int J Pharm 587, 119671 (2020).
Velino, C., et al. Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis. Front Bioeng Biotechnol 7, 406 (2019).
Deng, Z., Kalin, G.T., Shi, D. & Kalinichenko, V.V. Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases. Am J Respir Cell Mol Biol 64, 292–307 (2021).
Kang, H., et al. Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting. Adv Healthc Mater 9, e1901223 (2020).
Probst, C.K., Montesi, S.B., Medoff, B.D., Shea, B.S. & Knipe, R.S. Vascular permeability in the fibrotic lung. Eur Respir J 56(2020).
Yhee, J.Y., et al. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts. Int J Nanomedicine 12, 6089–6105 (2017).
Pandolfi, L., et al. Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis. Int J Mol Sci 22(2021).
Zhang, G., et al. Pulmonary delivery of therapeutic proteins based on zwitterionic chitosan-based nanocarriers for treatment on bleomycin-induced pulmonary fibrosis. Int J Biol Macromol 133, 58–66 (2019).
Kim, J., et al. Lung-targeted delivery of TGF-beta antisense oligonucleotides to treat pulmonary fibrosis. J Control Release 322, 108–121 (2020).
Keum, H., et al. Biomimetic lipid Nanocomplexes incorporating STAT3-inhibiting peptides effectively infiltrate the lung barrier and ameliorate pulmonary fibrosis. J Control Release 332, 160–170 (2021).
Kreyling, W.G., et al. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65, 1513–1530 (2002).
Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267, 89–105 (2010).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Snitow, M.E., Chaudhry, F.N., Zepp, J.A. (2023). Engineering and Modeling the Lung Mesenchyme. In: Magin, C.M. (eds) Engineering Translational Models of Lung Homeostasis and Disease. Advances in Experimental Medicine and Biology, vol 1413. Springer, Cham. https://doi.org/10.1007/978-3-031-26625-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-031-26625-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-26624-9
Online ISBN: 978-3-031-26625-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)